NCT06726395View on ClinicalTrials.gov

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

PHASE4RecruitingINTERVENTIONAL

Enrollment

420

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

July 31, 2028

Conditions

Staphylococcus Aureus BacteraemiaStaphylococcal BacteraemiaStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus (S.) Aureus Infection

Interventions

DRUG

Penicillin G_1200mg

benzylpenicillin preferred dosing 1gx4

DRUG

cloxacillin

cloxacillin 2gx4

Trial Locations (1)

22467

RECRUITING

Skånes universitetssjukhus, Region Skåne, Lund

All Listed Sponsors

lead

Region Skane

OTHER